04/04/2025
6:29 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
3:12 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2025
6:12 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
6:13 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 4/A | |
04/03/2025
6:14 PM | Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4/A | |
04/03/2025
6:15 PM | Fennec Pharmaceuticals (Issuer)
Sayad Pierre Sargis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
6:16 PM | Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4/A | |
04/03/2025
5:10 PM | Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
5:11 PM | Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
5:12 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
4:17 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for FENC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/01/2025
4:18 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
3:46 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
4:32 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:29 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
5:51 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
5:53 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:13 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
12:00 PM | Fennec Pharmaceuticals (Subject)
Solas Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
11:06 AM | DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
7:24 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:42 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
4:48 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:50 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:46 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:47 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
4:00 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:24 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:00 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
6:07 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
6:09 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:06 PM | Fennec Pharmaceuticals (Subject)
RALLIS CHRIS A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:02 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:13 PM | Fennec Pharmaceuticals (Issuer)
Sayad Pierre Sargis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:14 PM | Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:15 PM | Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
6:38 PM | DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
3:46 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
4:30 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
6:00 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Massive red flag about American consumer (Ad) Why is the U.S. Dollar suddenly crashing?
Pundits on either side of the aisle have been warning that the U.S. dollar would crash for years. In 2025, it looks like it finally is. What does that mean for you money... and was this President Trump's plan all along? A widely followed 25-year economist and investor explains exactly what's happening, what could come next, and how to position your money on this page here. See why America’s financial shift could unlock huge opportunities |
10/10/2024
4:14 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:11 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:13 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
4:02 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
5:33 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
5:48 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4/A | |
08/26/2024
4:51 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:59 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:00 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:00 PM | Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:01 PM | Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:02 PM | Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:56 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/13/2024
4:10 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:30 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:21 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
4:55 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:42 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:43 PM | DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G | |
06/03/2024
5:21 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:12 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:24 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:42 PM | Fennec Pharmaceuticals (Filer)
| Form DEF 14A | |
05/02/2024
3:59 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
